City

Worcester (1)

Condition

AMN (1)

AMN Gene Mutation (1)

B12 Deficiency Vitamin (1)

Neurologic Symptoms (1)

Nitrous Oxide Abuse (1)

Paresthesia (1)

Subacute Combined Cord Degeneration (1)

X-ALD (1)

X-linked Adrenoleukodystrophy (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Phase

phase 1/phase 2 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Nottingham University Hospitals NHS Trust (1)

SwanBio Therapeutics, Inc. (1)

Collaborator

Barts & The London NHS Trust (1)

Braintale (1)

Northern Care Alliance NHS Foundation Trust (1)

Sandwell & West Birmingham Hospitals NHS Trust (1)

The Royal Wolverhampton Hospitals NHS Trust (1)

University Hospital Birmingham NHS Foundation Trust (1)

Intervention

brainquant module of braintale-care platform (1)

imitation procedure (1)

observational study with no interventions (1)

sbt101 (1)

Study Documents

Intervention Type

device (1)

genetic (1)

other (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

Myeloneuropathy

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Neurological Recovery Following NOS-SACD

Not yet recruiting

Nitrous Oxide Abuse
+4 more

Observational study with no interventions

(no location specified)

Feb 2, 2023

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting

AMN
+2 more

SBT101
Imitation Procedure

Worcester, Massachusetts

University of Massachusetts Chan Medical School

Jun 1, 2022

Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

Not yet recruiting

X-linked Adrenoleukodystrophy

brainQuant module of brainTale-care platform

(no location specified)

Jun 12, 2023